Argenx Benefits Overview

Lead and optimize governance for the Senior Leadership Team, Operations Committee, and Portfolio Committee: prioritize agendas, build forum structure and charters, ensure high-impact prework, facilitate meetings to clear decisions and owners, publish and track actions, embed agile and AI-enabled ways of working, and develop capability across the organization.

Lead global market access strategy for Myasthenia Gravis and related FcRn pipeline assets. Define pricing, HTA/P&R positioning, evidence and HEOR plans, payer engagement, contracting and launch readiness. Align access strategy with development and commercial teams, manage external partners, and support lifecycle management and indication expansion.

Lead clinical development strategy and execution for assigned therapeutic indications, co-chair Clinical Development Team, oversee trial design, budgets, timelines, CRO/vendor management, risk mitigation, and regulatory interactions. May line-manage CTMs/CTAs, act as CTM for select trials, ensure ICH-GCP compliance, audit readiness, and cross-functional alignment across the program lifecycle.